JamesNormanLowderMD

PubMed

• 50 citations
  Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia
  Gail J. Roboz, Hagop M. Kantarjian, Karen W.L. Yee, Patricia Kropf, Casey O'Connell, Elizabeth A. Griffiths, Wendy Stock, Naval Daver, Elias Jabbour, Ellen K. Ritchie,...> ;Cancer. 2018 Jan 15
• 8 citations
  Will next-generation agents deliver on the promise of epigenetic hypomethylation therapy?
  James N. Lowder, Pietro Taverna, Jean Pierre J. Issa> ;Epigenomics. 2015 Nov 6
• 58 citations
  Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis.
  William J. Sandborn, Jean-Frederic Colombel, Matthew Frankel, Daan W. Hommes, James N. Lowder, Lloyd Mayer, S Plevy, Pieter C. F. Stokkers, Simon Travis, G. Van Assche...> ;Gut. 2010 Nov 1
• 36 citations
  Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis.
  Daniel C. Baumgart, Stephan R. Targan, Axel Dignass, Lloyd Mayer, Gert Van Assche, Daan W. Hommes, Stephen B. Hanauer, Uma Mahadevan, Walter Reinisch, Scott E. Plevy, ...> ;Inflammatory Bowel Diseases. 2010 Apr 1
• 19 citations
  Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn's disease.
  Daniel C. Baumgart, James N. Lowder, Stephan R. Targan, William J. Sandborn, Matthew Frankel> ;The American Journal of Gastroenterology. 2009 Apr 1
• 41 citations
  Natural History of Severe Ulcerative Colitis in a Community-Based Health Plan
  James E. Allison, Lisa J. Herrinton, Liyan Liu, Jenny Yu, James Lowder> ;Clinical Gastroenterology and Hepatology. 2008 Sep 1
• 92 citations
  A Phase I Study of Visilizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Severe Steroid-Refractory Ulcerative Colitis
  Scott E. Plevy, Bruce Salzberg, Gert Van Assche, Miguel Regueiro, Daniel W. Hommes, William J. Sandborn, Stephen B. Hanauer, Stephan R. Targan, Lloyd Mayer, Uma Mahade...> ;Gastroenterology. 2007 Nov 1
• 53 citations
  A Phase II Multicenter Study of Visilizumab, Humanized Anti-CD3 Antibody, to Treat Steroid-Refractory Acute Graft-versus-Host Disease
  Paul A. Carpenter, James Lowder, Laura Johnston, Haydar Frangoul, H Khoury, Pablo Parker, Keith R. Jerome, Jeannine S. McCune, Barry E. Storer, Paul J. Martin, Frederi...> ;Biology of Blood and Marrow Transplantation. 2005 Jun 1
• 15 citations
  Two-color immunofluorescence and flow cytometric analysis of peripheral blood lymphocyte subsets in Caucasian and Japanese healthy subjects.
  Masahiro Senju, Kazuya Makiyama, Kohei Hara, F. Hulstaert, James N. Lowder, Derek P. Jewell> ;Japanese Journal of Medicine. 1991 Nov 1
• 39 citations
  Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease.
  M. Senju, F. Hulstaert, James N. Lowder, Derek P. Jewell> ;Gut. 1991 Jul 1
• 1 citations
  Monocytic leukemoid reaction, glucocorticoid therapy, and myelodysplastic syndrome.
  Manoel Moraes, John Wilkes, James N. Lowder> ;Cleveland Clinic Journal of Medicine. 1990 Sep 1
• High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy.
  Brown RA, Herzig RH, Wolff SN, Frei-Lahr D, Pineiro L, Bolwell BJ, Lowder JN, Harden EA, Hande KR, Herzig GP> ;Blood. 1990-08-01
• 82 citations
  High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies.
  Steven N. Wolff, Roger H. Herzig, Joseph W. Fay, C. Fred LeMaistre, Randy A. Brown, Debra Frei-Lahr, Sarah Stranjord, Leonard Giannone, Peter F. Coccia, James L. Weick...> ;Seminars in Oncology. 1990 Feb 1
• High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow T...
  Wolff, S. N., Herzig, R. H., Fay, J. W., LeMaistre, C. F., Frei-Lahr, D., Lowder, J., Bolwell, B., Giannone, L., Herzig, G. P.> ;J Clin Oncol. 1989 Feb
• 11 citations
  A Prospective Randomized Trial of Central Venous Catheter Removal Versus Intravenous Amphotericin B in Febrile Neutropenic Patients
  Hillard M. Lazarus, James N. Lowder, James M. Anderson, Roger H. Herzig> ;JPEN. Journal of Parenteral and Enteral Nutrition. 1984 Sep 1
• 63 citations
  Occlusion and infection in broviac catheters during intensive cancer therapy
  Hillard M. Lazarus, James N. Lowder, Roger H. Herzig> ;Cancer. 1983 Dec 15
• 116 citations
  Bacteremias and Fungemias in Oncologic Patients With Central Venous Catheters: Changing Spectrum of Infection
  James N. Lowder, Hillard M. Lazarus, Roger H. Herzig> ;Archives of Internal Medicine. 1982 Aug 1
• 13 citations
  Bacteremic pneumococcal epiglottitis in adults with malignancy.
  Michael M. Lederman, James N. Lowder, Phillip I. Lerner> ;The American Review of Respiratory Disease. 1982 Jan 1
• Macular and paramacular detachment of the neurosensory retina associated with systemic diseases.
  Lowder, C. Y., Gutman, F. A., Zegarra, H., Zakov, Z. N., Lowder, J. N., Clough, J. D.> ;Trans Am Ophthalmol Soc. 1981
• Join now to see all